0.050
0.00 (-9.09%)
| Previous Close | 0.055 |
| Volume | 18,910 |
| Price / Sales | 0.120 |
| 52 Weeks Range |
| Profit Margin | -61.07% |
| Operating Margin (TTM) | -23.10% |
| Diluted EPS (TTM) | -0.550 |
| Quarterly Revenue Growth (YOY) | 16.50% |
| Current Ratio (MRQ) | 0.220 |
| Operating Cash Flow (TTM) | -2.38 M |
| Levered Free Cash Flow (TTM) | -3.03 M |
| Return on Assets (TTM) | -26.43% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Mixed | Mixed |
| Medical Devices (Global) | Mixed | Mixed | |
| Stock | Biotricity Inc. | Mixed | Mixed |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | NA |
| Price Volatility | 0.5 |
| Technical Moving Averages | 5.0 |
| Technical Oscillators | -2.5 |
| Average | 0.50 |
|
Biotricity Inc is a medical technology company that focuses on biometric data monitoring solutions. It aims to deliver remote monitoring solutions to the healthcare & consumer markets, with a focus on diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. Biotricity is expanding medical-grade monitoring into the consumer market via its Biolife solution, which empowers users to self-manage chronic conditions. Its products include Bioflux, which is a mobile cardiac telemetry (MCT) device that provides real-time monitoring and transmission of ambulatory patients' ECG information; Biocare Telemed; Bioheart, which is a personal heart monitor; Biokit, and Biocare health. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Growth |
| % Held by Insiders | 39.37% |
| % Held by Institutions | 2.51% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Strengthening Families & Communities, Llc | 31 Dec 2025 | 0 |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |